2-methylpentane has been researched along with Encephalopathy, Toxic in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Li, M; Li, X; Liu, Z; Wang, Q; Wang, S; Xie, K; Yu, T | 1 |
Spencer, PS | 1 |
Alves, C; Bitencourt, S; de Souza, CFV; Goettert, MI; Kich, DM; Laufer, S; Pedrosa, R; Pinteus, S; Silva, J | 1 |
Kayton, R; Lasarev, M; Monterroso, V; Sabri, M; Spencer, P; Tshala-Katumbay, D | 1 |
DeCaprio, AP; Kinney, EA; LoPachin, RM | 1 |
Cohr, KH; Jørgensen, NK | 1 |
Bergh, JJ; Castagnoli, N; Fourie, H; Ogunrombi, MO; Petzer, JP; Pretorius, A; Terre'blanche, G | 1 |
Banno, H; Hashizume, A; Ishii, A; Ito, M; Kaneko, R; Katsuno, M; Kawagashira, Y; Koike, H; Naganawa, S; Sobue, G; Suzuki, K; Tanaka, F; Watanabe, H | 1 |
Lao, XQ; Yu, DX; Zhu, DX | 1 |
3 review(s) available for 2-methylpentane and Encephalopathy, Toxic
Article | Year |
---|---|
Neuroprotein Targets of γ-Diketone Metabolites of Aliphatic and Aromatic Solvents That Induce Central-Peripheral Axonopathy.
Topics: Animals; Hexanes; Humans; Nerve Degeneration; Neurons; Neurotoxicity Syndromes; Organic Chemicals; Solvents | 2020 |
N-hexane and its toxicologic effects: a review.
Topics: Adhesives; Biotransformation; Hexanes; Humans; Inhalation Exposure; Neurotoxicity Syndromes | 1981 |
[The Effect biomarkers of n-hexane peripheral neurotoxicity].
Topics: Animals; Biomarkers; Hexanes; Humans; Neurotoxicity Syndromes | 2012 |
7 other study(ies) available for 2-methylpentane and Encephalopathy, Toxic
Article | Year |
---|---|
Diallyl sulfide-induced attenuation of n-hexane-induced peripheral nerve impairment is associated with metabolic inhibition of n-hexane.
Topics: Allyl Compounds; Animals; Body Weight; Hair; Hexanes; Hexanones; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Pyrroles; Rats, Wistar; Sciatic Nerve; Sulfides | 2020 |
Neuromodulatory effects of Calyptranthes grandifolia extracts against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.
Topics: Acetylcholinesterase; Caspase 3; Cell Line, Tumor; Cell Survival; Ethanol; Hexanes; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinase 10; Myrtaceae; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Oxidopamine; Plant Extracts | 2016 |
Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.
Topics: Acetophenones; Amino Acids; Animals; Axons; Biomarkers; Cell Shape; Electrophoresis, Polyacrylamide Gel; Hexanes; Hexanones; Isoelectric Focusing; Male; Nerve Tissue Proteins; Neurofilament Proteins; Neurotoxicity Syndromes; Neurotoxins; Proteomics; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spinal Cord | 2009 |
Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
Topics: Animals; Axons; Cytoskeletal Proteins; Ergosterol; Hexanes; Hexanones; Male; Molecular Structure; Neurotoxicity Syndromes; Rats; Rats, Wistar; Spinal Cord | 2009 |
Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
Topics: Animals; Hexanes; Kinetics; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Monoamine Oxidase; Neurotoxicity Syndromes; Papio; Pyrrolidines | 2010 |
Central nervous system involvement in n-hexane polyneuropathy demonstrated by MRI and proton MR spectroscopy.
Topics: Biopsy; Brain; Central Nervous System Diseases; Female; Gas Chromatography-Mass Spectrometry; Hexanes; Humans; Inhalant Abuse; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Neurologic Examination; Neurotoxicity Syndromes; Polyneuropathies; Sural Nerve | 2011 |
n-Hexane-related peripheral neuropathy among automotive technicians--California, 1999-2000.
Topics: Adult; Automobiles; California; Hexanes; Humans; Male; Neurotoxicity Syndromes; Occupational Diseases; Peripheral Nervous System Diseases; Solvents | 2001 |